Q3 2023

Filed Nov 14, 2023 · 10-Q · 45 days after period end · 0001493152-23-041311

Q3 2023 · 10-Q

Revenue

$17.52K

−57.3% vs Q3 2022

Net Income

-$37.67K

N/M vs Q3 2022

EPS, diluted—

Operating Income-$37,445N/M

Operating Cash Flowderived-$40,560N/M

Same quarter

Metric	Q3 2023	Q3 2022	Q3 2021	Q3 2020
Revenue	$17.52K	$41.00K	—	$0.00
Net Income	-$37.67K	-$5.44K	-$20.83K	-$25.64K
EPS Diluted	—	—	$0.00	$0.00

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

NP Life Sciences Health Industry Group Inc. · CIK 1781726 · Engraved from SEC EDGAR